ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
2941Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 15,200 shares, the number of shares held decreased 3.24% compared to the previous period and now represents 0.5% of the total position.
ARKG Investment Tracker position change: Decreased position in Eli Lilly by 375 shares, the number of shares held decreased 3.2% compared to the previous period and now represents 0.94% of the total position.
ARKG Investment Tracker position change: Decreased position in BioNTech SE by 3,825 shares, the number of shares held decreased 3.24% compared to the previous period and now represents 1.05% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 332,750 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 1.5% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 8,700 shares, the number of shares held decreased 3.24% compared to the previous period and now represents 1.76% of the total position.
ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 148,900 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 1.51% of the total position.
ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 100,225 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 1.78% of the total position.
ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 485,242 shares, the number of shares held decreased 9.92% compared to the previous period and now represents 2.15% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 63,275 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 2.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 64,175 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 2.47% of the total position.
ARKG Investment Tracker position change: Decreased position in CareDx by 60,750 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 3.47% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 12,125 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 2.13% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 52,100 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 2.43% of the total position.
ARKG Investment Tracker position change: Decreased position in Veracyte by 30,225 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 2.72% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 14,975 shares, the number of shares held decreased 3.24% compared to the previous period and now represents 3.61% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 7,350 shares, the number of shares held decreased 3.24% compared to the previous period and now represents 4.09% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 91,850 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 3.66% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 379,350 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 3.82% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 129,820 shares, the number of shares held decreased 6.72% compared to the previous period and now represents 9.63% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 67,125 shares, the number of shares held decreased 3.25% compared to the previous period and now represents 5.61% of the total position.
Go to Tiger App to see more news